Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Ann Cardiol Angeiol (Paris) ; 68(6): 418-422, 2019 Dec.
Article in French | MEDLINE | ID: mdl-31668597

ABSTRACT

After a first procedure carried out in 2002 by Pr Cribier's, Transcatheter Aortic Valve Replacement or TAVR revolutionized the management of aortic stenosis with a constant increase in the number of procedures performed worldwide. Experience of operators and teams and evolution of the technique has been accompanied by a drastic reduction in complications in patients at lower surgical risk. In parallel, the procedure was considerably simplified, carried out more and more under local anesthesia, with percutaneous femoral approach, secondary radial approach, prosthesis implantation without predilatation, rapid pacing on left ventricle wire and early discharge. Thus, the "simplified" TAVR adopted in most centers nowadays is a real revolution of the technique. However, simplified TAVR must be accompanied upstream by a rigorous selection of patients who can benefit from a minimalist procedure in order to guarantee its safety.


Subject(s)
Aortic Valve Stenosis/surgery , Patient Selection , Transcatheter Aortic Valve Replacement/methods , Anesthesia, Conduction/methods , Anesthesia, Local , Cardiac Catheterization/instrumentation , Cardiac Catheterization/methods , Conscious Sedation , Femoral Artery , Heart Valve Prosthesis Implantation/methods , Humans , Hypotension, Controlled/methods , Patient Care Team , Postoperative Complications/diagnosis , Postoperative Complications/prevention & control , Radial Artery , Transcatheter Aortic Valve Replacement/adverse effects , Transcatheter Aortic Valve Replacement/trends , Work Simplification
2.
Ann Cardiol Angeiol (Paris) ; 66(6): 441-446, 2017 Dec.
Article in French | MEDLINE | ID: mdl-29106834

ABSTRACT

Atrial fibrillation (AF) is frequent and responsible for embolic events. Currently, the gold standard to prevent such embolic events is anticoagulant therapy with vitamin K antagonist (VKA) or direct oral anticoagulant in nonvalvular AF. Recently, left atrial appendage closure was proposed as an alternative to anticoagulant inpatient with high embolic risk and contraindication to anticoagulant therapy. Data from randomized trials were consistent with a non-inferiority of left atrial appendage closure in comparison to VKA in terms of stroke and cardiovascular death. However, despite improvements in procedure results and complications reduction, this invasive strategy has to be performed with optimal security as this strategy is a preventive treatment in high-risk patients. These improvements may allow an extension of indications of left atrial appendage closure to lower profile risk patients as an alternative to anticoagulant. Indeed, anticoagulant is a risky therapy with hemorrhagic events and observance is a real issue in an asymptomatic population. Finally, there is a lack of data in recent literature comparing left atrial appendage closure to direct oral anticoagulant, widely used in daily practice, as well as cost-effectiveness of this procedure in comparison to anticoagulant.


Subject(s)
Anticoagulants , Atrial Appendage/surgery , Atrial Fibrillation/complications , Atrial Fibrillation/surgery , Stroke/prevention & control , Thromboembolism/prevention & control , Anticoagulants/economics , Anticoagulants/therapeutic use , Atrial Fibrillation/economics , Cost-Benefit Analysis , France , Humans , Randomized Controlled Trials as Topic , Risk Factors , Stroke/economics , Stroke/etiology , Thromboembolism/economics
3.
Ann Cardiol Angeiol (Paris) ; 66(6): 415-420, 2017 Dec.
Article in French | MEDLINE | ID: mdl-29096901

ABSTRACT

Cardiovascular disease in women is a particularly complex pathology especially in the youngest population. The clinical presentation of acute coronary syndromes is sometimes misleading and does not necessarily point to the potential presence of cardiac disease given the frequent absence of cardiovascular risks. Such complexity results in delayed diagnosis, which worsens the outcome of myocardial infarction and generates complications related to the absence of coronary revascularization. We report the case of a patient who suffered an (undiagnosed) apical myocardial infarction that went undetected and was complicated by a voluminous intraventricular thrombus with embolus migration in the cerebral circulation resulting in an ischemic accident. The combination of these two pathologies make their therapeutic management particularly difficult. As widely reported in the literature, the outcome of myocardial infarction in women is poorer than in their male counterparts for a number of reasons. We can assume that in the youngest patients, another physiopathological mechanism is often involved, namely, the occurrence of hematoma and spontaneous coronary dissection. Diagnosis is often difficult even with coronary angiography diagnosis. As shown in the case reported here, initial examination results, if not thoroughly analyzed, may be erroneously interpreted as normal. It is also likely that the presence of hematoma or coronary wall dissection without any plaque rupture may negatively influence the outcome owing to the implementation of inappropriate treatments. In conclusion, in patients presenting with an ischemic cerebral accident, meticulous cardiac examination must be performed even in young women with no cardiovascular risk factors given that the occurrence of hematoma or coronary dissection may contribute to the formation of mural thrombi in the setting of myocardial infarction. Cardiac MRI seems to be particularly effective in the diagnosis of myocardial infarction complicated by the presence of intracavitary thrombi.


Subject(s)
Anterior Wall Myocardial Infarction/complications , Anticoagulants/administration & dosage , Brain Ischemia/etiology , Overweight/complications , Stroke/etiology , Administration, Oral , Adult , Angiography/methods , Anterior Wall Myocardial Infarction/blood , Anterior Wall Myocardial Infarction/diagnosis , Anterior Wall Myocardial Infarction/drug therapy , Biomarkers/blood , Body Mass Index , Brain Ischemia/diagnosis , Brain Ischemia/drug therapy , Coronary Angiography/methods , Electrocardiography , Emergencies , Female , Humans , Overweight/diagnosis , Risk Factors , Stroke/diagnosis , Stroke/drug therapy , Treatment Outcome , Troponin I/blood
SELECTION OF CITATIONS
SEARCH DETAIL